Zhou, K., Hou, S., Zhang, Y., Li, F., Yang, W., Yi, T., Lin, N., Meng, W., Liu, X., Chen, Y., Lu, Q., Tian, W., Song, Y. (2025). Updated efficacy and safety results from the phase 2 study of timdarpacept in combination with tislelizumab in patients with classical Hodgkin lymphoma for whom prior anti–PD-1 therapy failed.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7041